Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression and the potential functions of TRIM32 in lung cancer tumorigenesis
Hongmei Yin, Zhen Li, Jia Chen, et al.
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 4, pp. 5232-5243
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis
Santina Venuto, Giuseppe Merla
Cells (2019) Vol. 8, Iss. 5, pp. 510-510
Open Access | Times Cited: 128
The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
Michael A. Mandell, Bhaskar Saha, Todd A. Thompson
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 50
TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets
Weihua Zhan, Song Zhang
Life Sciences (2021) Vol. 268, pp. 118985-118985
Closed Access | Times Cited: 46
TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma
Qingyu Luo, Xiaowei Wu, Yabing Nan, et al.
Cell Reports (2020) Vol. 30, Iss. 1, pp. 98-111.e5
Open Access | Times Cited: 44
The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
Zhao Guo, Chuan Liu, Xin Wen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107881-107881
Closed Access | Times Cited: 40
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
TRIM32: A Multifunctional Protein Involved in Muscle Homeostasis, Glucose Metabolism, and Tumorigenesis
Simranjot Bawa, Rosanna Piccirillo, Erika R. Geisbrecht
Biomolecules (2021) Vol. 11, Iss. 3, pp. 408-408
Open Access | Times Cited: 25
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases
Nieves Lara-Ureña, Vahid Jafari, Mario García‐Domínguez
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8012-8012
Open Access | Times Cited: 18
E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers
Shu‐Chun Chang, Bo-Xiang Zhang, Jeak Ling Ding
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188679-188679
Open Access | Times Cited: 17
TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1
Katrine Stange Overå, Juncal Garcia‐Garcia, Zambarlal Bhujabal, et al.
Journal of Cell Science (2019) Vol. 132, Iss. 23
Open Access | Times Cited: 26
TRIM-NHL as RNA Binding Ubiquitin E3 Ligase (RBUL): Implication in development and disease pathogenesis
Shanikumar Goyani, Milton Roy, Rajesh Singh
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 7, pp. 166066-166066
Open Access | Times Cited: 22
The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells
Xiaoxia Shi, Yixin Du, Shujing Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3639-3639
Open Access | Times Cited: 16
TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer
Yan Ma, Haibo Zhang, Cheng Chen, et al.
Oncogene (2022) Vol. 41, Iss. 11, pp. 1589-1599
Closed Access | Times Cited: 15
The Role of Tripartite Motif Family Proteins in TGF-β Signaling Pathway and Cancer
Ho-Jae Lee
Journal of Cancer Prevention (2018) Vol. 23, Iss. 4, pp. 162-169
Open Access | Times Cited: 25
TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance
Flaviana Marzano, Mariano Francesco Caratozzolo, Graziano Pesole, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 241-241
Open Access | Times Cited: 18
TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway
Zhao Chen, Lifang Tian, Li Wang, et al.
Inflammation (2021) Vol. 45, Iss. 3, pp. 992-1006
Closed Access | Times Cited: 18
Emerging Role of TRIM Family Proteins in Cardiovascular Disease
Jingrui Zhang, Xinxin Li, Wanning Hu, et al.
Cardiology (2020) Vol. 145, Iss. 6, pp. 390-400
Closed Access | Times Cited: 20
Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis
Dennis M. Timmerman, Tessa L. Remmers, Sanne Hillenius, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5377-5377
Open Access | Times Cited: 17
Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 Axis
Qingjie Meng, Linlin Wang, Yonggang Lv, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 36, Iss. 1, pp. 23-35
Closed Access | Times Cited: 17
TRIM proteins in breast cancer: Function and mechanism
Xin De Bai, Jianming Tang
Biochemical and Biophysical Research Communications (2022) Vol. 640, pp. 26-31
Closed Access | Times Cited: 10
Functionalized Parylene Films for Enhancement of Antibody Production by Hybridoma Cells
Tae‐Hun Kim, Zhiquan Song, Jaeyong Jung, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 9, pp. 3726-3738
Closed Access | Times Cited: 5
The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas
Veronica Gatti, Francesca Bernassola, Claudio Talora, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1595-1595
Open Access | Times Cited: 14
Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner
Yu Cai, Wei Gu, Kang Cheng, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 550, pp. 134-141
Closed Access | Times Cited: 12
TRIM proteins in neuroblastoma
Yonghu Xu, Zihan Zhang, Guofeng Xu
Bioscience Reports (2019) Vol. 39, Iss. 12
Open Access | Times Cited: 12
Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
Guangzhen Wu, Yingkun Xu, Li Lin, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 18, pp. 2905-2916
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top